0001567619-19-005281.txt : 20190222 0001567619-19-005281.hdr.sgml : 20190222 20190222172735 ACCESSION NUMBER: 0001567619-19-005281 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190219 FILED AS OF DATE: 20190222 DATE AS OF CHANGE: 20190222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HULME GEOFFREY CENTRAL INDEX KEY: 0001307047 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 19627391 MAIL ADDRESS: STREET 1: C/O PORTER ORLIN LLC STREET 2: 666 FIFTH AVENUE, 34TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4/A 1 doc1.xml FORM 4/A X0306 4/A 2019-02-19 2019-02-20 0 0001080014 Innoviva, Inc. INVA 0001307047 HULME GEOFFREY 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 0 1 0 0 Interim PEO Common Stock 2019-02-19 4 F 0 3093 14.53 D 12907 D The form is being amended to reflect granted shares withheld by the Issuer to satisfy income tax withholding obligations incurred in connection with the grant of the restricted stock award described in the original filing. /s/ Geoffrey L. Hulme 2019-02-22